CureVac’s Covid-19 Vaccine Disappoints in Clinical Trial A preliminary analysis showed that CureVac’s mRNA vaccine had an efficacy of just 47 percent. “This is pretty devastating for them,” one expert said. https://ift.tt/2XidLiy https://nyti.ms/3eyQv5F

A preliminary analysis showed that CureVac’s mRNA vaccine had an efficacy of just 47 percent. “This is pretty devastating for them,” one expert said.

from NYT > Top Stories https://nyti.ms/3zxvrYE
via IFTTT